SIGA - CDC announces emergency operations center for monkeypox

The Centers for Disease Control and Prevention (CDC) announced on Tuesday the activation of an emergency operations center for monkeypox response in an attempt to monitor and coordinate its activities against the rare viral disease. Home to more than 300 staff, the center will bring together additional CDC personnel and resources for the response, the agency said. “CDC’s activation of the EOC allows the agency to further increase operational support for the response to meet the outbreak’s evolving challenges,” the CDC added. Developers of monkeypox therapeutics: GeoVax Labs (GOVX), SIGA Technologies (NASDAQ:SIGA), and Tonix Pharmaceuticals (TNXP) Vaccine developers for monkeypox: Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), Emergent BioSolutions (EBS), Chimerix (CMRX) Monkeypox test developers: Co-Diagnostics (CODX), Abbott (ABT), Roche (OTCQX:RHHBY) (OTCQX:RHHBF) After a meeting of an advisory committee, the World Health Organization (WHO) said last week that the current outbreak of monkeypox did not amount to a global public health emergency. However, the panel

For further details see:

CDC announces emergency operations center for monkeypox